Publication Archive - Page 5 sur 18

Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023

Antunes Liliana, Mazagatos Clara, Martínez-Baz Iván, Gomez Verónica, Borg Maria-Louise, Petrović Goranka, Duffy Róisín, Dufrasne François E, Dürrwald Ralf, Lazar Mihaela, Jancoriene Ligita, Oroszi Beatrix, Husa Petr, Howard Jennifer, Melo Aryse, Pozo Francisco, Pérez-Gimeno Gloria, Castilla Jesús, Machado Ausenda, Džiugytė Aušra, Karabuva Svjetlana, Fitzgerald Margaret, Fierens Sébastien, Tolksdorf Kristin, Popovici Silvia-Odette, Mickienė Auksė, Túri Gergő, Součková Lenka, Nicolay Nathalie, Rose Angela MC, on behalf of the European Hospital Vaccine Effectiveness Group.

Euro Surveill. 2024;29(3):pii=2300708.

Available here

Generic protocol for ECDC studies of COVID-19 vaccine effectiveness against confirmed SARS-CoV-2 using healthcare worker cohorts, v.2.0

Camelia Savulescu, Esther Kissling, Anthony Nardone

Stockholm: ECDC; 2022.

Available here

Generic protocol for ECDC studies of influenza vaccine effectiveness against confirmed infection using healthcare worker cohorts – version 2.0

Camelia Savulescu, Esther Kissling, Anthony Nardone

European Centre for Disease Prevention and Control. Stockholm: ECDC; 2024.

Available here

Ultra-processed food consumption in Barbados: evidence from a nationally representative, cross-sectional study

Harris RM, Rose AMC, Soares-Wynter S, Unwin N

J Nutrit Sci 2021: (10)e29; doi:10.1017/jns.2021.21.

Available here

Consumo de productos alimentarios ultraprocesados y procesados con exceso de nutrientes asociados a las enfermedades crónicas no transmisibles y a la alimentación insalubre en las Américas

PAHO report 2021; OPS/NMH/RF/21-0036

Available here

Enhanced surveillance of hospitalised COVID-19 patients in Europe: I-MOVE-COVID-19 surveillance network, February 2020 to December 2021

Mutch H, Young JJ, Sadiq F, Rose AMC, Evans JMM, on behalf of the European COVID-19 hospital surveillance analysis writing group

Euro Surveill. 2023;28(26):pii=2200669

Available here

Enhanced surveillance of hospitalized COVID-19 patients in Europe: an evaluation of the I-MOVE-COVID-19 surveillance network, European Journal of Public Health, 2023

Johanna J Young, Heather Mutch, Angela M C Rose, Josie M M Evans, the European COVID-19 Hospital Evaluation Writing Group

ckad185

Available here

Prévention de la coqueluche chez le nouveau-né : faut-il vacciner les femmes enceintes à chaque grossesse ?

Niaré D, Debin M, Merdrignac L, Blanchon T, Hanslik T, Steichen O,

Rev Med Interne, 2023, ISSN 0248-8663, https://doi.org/10.1016/j.revmed.2023.06.007

Available here

Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023

Fontán-Vela Mario, Kissling Esther, Nicolay Nathalie, Braeye Toon, Van Evercooren Izaak, Holm Hansen Christian, Emborg Hanne-Dorthe, Fabiani Massimo, Mateo-Urdiales Alberto, AlKerwi Ala’a, Schmitz Susanne, Castilla Jesús, Martínez-Baz Iván, de Gier Brechje, Hahné Susan, Meijerink Hinta, Starrfelt Jostein, Nunes Baltazar, Caetano Constantino, Derrough Tarik, Nardone Anthony, Monge Susana, VEBIS-Lot4 working group.

Euro Surveill. 2024;29(1):pii=2300670

Available here

Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study

Maurel M, Pozo F, Pérez-Gimeno G, et al.

Influenza Other Respi Viruses. 2024; 18(1):e13243. doi:10.1111/irv.13243

Available here

Publication

Référencement Centrales d'achats

Hébergement de données de santé

Engagement et éthique